The 10-day RSI Indicator for IMAX moved out of overbought territory on December 04, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 instances where the indicator moved out of the overbought zone. In of the 29 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IMAX as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IMAX turned negative on December 04, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IMAX broke above its upper Bollinger Band on November 27, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMAX advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 209 cases where IMAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.070) is normal, around the industry mean (5.729). P/E Ratio (34.435) is within average values for comparable stocks, (92.419). Projected Growth (PEG Ratio) (0.861) is also within normal values, averaging (2.987). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (2.330) is also within normal values, averaging (29.638).
a manufacturer of projection and sound systems for large screen theaters
Industry MoviesEntertainment
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICEUX | 38.75 | -0.07 | -0.18% |
NYLI Epoch International Choice Class I | |||
FZAFX | 26.75 | -0.07 | -0.26% |
Fidelity Advisor Equity Growth Z | |||
NBRIX | 14.40 | -0.05 | -0.34% |
Neuberger Berman Real Estate I | |||
JETAX | 14.70 | -0.09 | -0.61% |
abrdn Global Equity Impact A | |||
MNSQX | 23.11 | -0.28 | -1.20% |
Invesco Main Street Small Cap R5 |
A.I.dvisor indicates that over the last year, IMAX has been loosely correlated with MCS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAX jumps, then MCS could also see price increases.
Ticker / NAME | Correlation To IMAX | 1D Price Change % | ||
---|---|---|---|---|
IMAX | 100% | +0.44% | ||
MCS - IMAX | 43% Loosely correlated | +0.23% | ||
CNK - IMAX | 43% Loosely correlated | -1.90% | ||
NXST - IMAX | 30% Poorly correlated | -1.14% | ||
AMC - IMAX | 29% Poorly correlated | +4.68% | ||
LUCK - IMAX | 28% Poorly correlated | +2.19% | ||
More |